1. Fixed-Interval Versus OCT-Guided Variable Dosing of Intravitreal Bevacizumab in the Management of Neovascular Age-Related Macular Degeneration: A 12-Month Randomized Prospective Study - Corrected Proof

    American Journal of Ophthalmology (Oct 18 2011)

    1. Purpose: To compare the efficacy of as-needed or variable dosing of intravitreal bevacizumab to continuous fixed-interval dosing in the management of neovascular age-related macular degeneration (AMD).Design: Prospective, open-label, randomized clinical study.Methods: One hundred twenty eyes of 120 patients with treatment-naïve subfoveal neovascular AMD participated in this study at ... (Read Full Article)

      Bookmark or Share this article

    Login to comment